Evidence-Based Management of Oral Mucositis | JCO Oncology …
WEBFeb 3, 2020 · The morbidity of oral mucositis includes pain, nutritional compromise, and infection risk, which potentially result in breaks or dose reductions in cancer therapy. Historically, management was focused mainly on pain control and nutritional support. However, evidence-based clinical practice guidelines for …
Antiemetics: ASCO Guideline Update | Journal of Clinical Oncology
WEBJul 13, 2020 · The first ASCO guideline for antiemetics was published in 1999, 1 with updates in 2006, 2 2011, 3 2015, 4 and 2017. 5 This update of the 2017 guideline provides guidance on the use of dexamethasone as a prophylactic antiemetic in patients receiving CPIs. This guideline update addresses programmed death-1 (PD-1), programmed death 1–ligand (PD ...
Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline
WEBPURPOSE To provide guidance to clinicians regarding therapy for patients with brain metastases from solid tumors. METHODS ASCO convened an Expert Panel and conducted a systematic review of the literature. RESULTS Thirty-two randomized trials published in 2008 or later met eligibility criteria and form the primary evidentiary base. RECOMMENDATIONS Surgery is a reasonable option for patients ...
Latest Advances in the Diagnosis and Treatment of Large Granular ...
WEBMay 23, 2018 · Large granular lymphocyte (LGL) leukemia is an indolent lymphoproliferative disorder that belongs to mature T and natural killer (NK) cell neoplasms and is recognized as cytotoxic T and NK cell lymphomas and leukemia in the 2016 World Health Organization classification. 1 Two subtypes of chronic LGL proliferation are described, T-LGL and NK-LGL, which account for more than 85% and 10% of cases ...
Does size matter? Lesion size as an indicator of number of cores …
WEBFeb 19, 2020 · 283 Background: MRI/US fusion guided prostate biopsy (FBx) has been shown to detect clinically significant prostate cancer (csCaP) at higher rates and with fewer cores than standard prostate biopsy. Size plays an important role in assigning a suspicion level (PI-RADS) to lesions identified on MRI. However, tumor characteristics may pose challenges to accurately characterizing the lesion ...
WEBThe rst ASCO guideline for antiemetics was published fi in 1999,1with updates in 2006,22011,32015,4and 2017.5 This update of the 2017 guideline provides guidance on the use of dexamethasone as a pro-phylactic antiemetic in patients receiving CPIs. This guideline update addresses programmed death-1 (PD-1), programmed death 1 …
ASCO Annual Meeting | ASCO Daily News
WEBJune 19, 2024. Dr. Diwakar Davar and Dr. Jason Luke discuss advances in the neoadjuvant immunotherapy space that were presented at the 2024 ASCO Annual Meeting, including promising outcomes in high-risk melanoma from the NADINA trial, as well as other new treatment options for patients with advanced cancers. Breast Cancer.
WEBTHE BOTTOM LINE VenousThromboembolism ProphylaxisandTreatmentin PatientsWithCancer:ASCOClinicalPractice Guideline Update Guideline Question How should venous thromboembolism (VTE) be prevented and treated in patients with cancer?
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO …
WEBThere were approximately 670,000 new cases and 625,000 deaths worldwide due to hepatocellular carcinoma (HCC) in 2018. HCC comprises 75%-85% of primary liver cancer cases and is the fourth-leading cause of annual cancer deaths worldwide. 1 In the United States, it is estimated that liver cancer will account for approximately 42,810 new cases and approximately 30,160 deaths in 2020. 2 Risk ...
What Makes a Pancreatic Cancer Resectable? | American Society of ...
WEBMay 23, 2018 · There is an evolving recognition that pancreatic cancer is a systemic disease at the time of diagnosis, even among patients with apparent localized disease. 4 As a result, and supported by recent data demonstrating improved overall survival for patients who are treated with multimodality therapy as compared with surgery alone, greater attention has been focused on the optimal treatment ...